News
GlaxoSmithKline and Theravance have been marching right along. All four of their next-generation long-lasting treatments were approved by the FDA, offering hope that a successful product launch ...
How did GlaxoSmithKline flourish in the financial ... What has changed to allow GSK to remain in this position of success? In times before the internet, corporations had secrets.
GlaxoSmithKline PLC is a pharmaceutical giant ... the GSK and Novartis Consumer businesses’ joint venture with great success. The EMpower 50 Advocates Role Models 2022 named Diana Conrad as ...
Read our privacy notice. GlaxoSmithKline's global head of yax, Melissa Geiger, shares the secrets to her success, including staying one step ahead of a fast-moving industry and switching off with ...
The trial evaluated the combination of GSK’s Jemperli and Zejula as a first-line therapy for stage III and IV epithelial OC.
The leading firms in the global Decongestant Nasal Spray market are examined for respective market share, historical turn of events, latest flagship releases, and organization mergers. Similarly ...
Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract infections early as the study met its main goal, the companies said on ...
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results